Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations

Journal of Endocrinological Investigation

Volumn 31, Issue 11, 2008, Pages 946-949

  Ruggeri, R M ^a   Santarpia, L ^a,b   Curto L ^a   Torre, M L ^a   Galatioto, M ^a   Galatioto, S ^a   Trimarchi, F ^a   Cannavo S ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

318C>G singre nucleotide polymorphism; G proteins; GNAI2A; GNASI; Non functioning pituitary adenomas

Indexed keywords

CYTIDINE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANOSINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; THYMIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROSURGERY; NONFUNCTIONING PITUITARY ADENOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 59849084828     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345630     Document Type: Article

References (18)

1. Gittoes NJ. Current perspectives on the pathogenesis of clinically non-functioning pituitary tumours. J Endocrinol 1998, 157: 177-86.
2. Alexander JM, Biller BM, Bikkal H, Zervas NT, Arnold A, Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 1990, 86: 336-40.
3. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990, 71: 1427-33.
4. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nat Rev Cancer 2002, 2: 836-49.
5. Levy A, Lightman S. Molecular defects in the pathogenesis of pituitary tumours. Front Neuroendocrinol 2003, 24: 94-127.
6. Lania A, Mantovani G, Spada A. Genetics of pituitary tumours: focus on G-protein mutations. Exp Biol Med (Maywood) 2003, 228: 1004-17.
7. Landis CA, Harsh G, Lyons J, Davis RL, McCormick F, Bourne HR. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J Clin Endocrinol Metab 1990, 71: 1416-20.
8. Spada A, Arosio M, Bochicchio D, et al. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively activated adenylyl cyclase. J Clin Endocrinol Metab 1990, 71: 1421-6.
9. Tordjman K, Stern N, Ouaknine G, et al. Activating mutations of the Gs alpha-gene in non-functioning pituitary tumors. J Clin Endocrinol Metab 1993, 77: 765-9.
10. Williamson EA, Daniels M, Kendall-Taylor P, Harris PE. Gs alpha and Gi alpha mutations in 'non-functioning' pituitary tumours. Clin Endocrinol (Oxf) 1994, 41: 815-20.
11. Kan B, Esapa C, Sipahi T, et al. G protein mutations in pituitary tumors: a study on Turkish patients. Pituitary 2003, 6: 75-80.
12. Williamson EA, Harrison D, Ince PG, Kendall-Taylor P, Harris PE. G-protein mutations in human pituitary adrenocorticotrophin hormone-secreting adenomas. Eur J Clin Invest 1995, 25: 128-31.
13. Boston BA, Mandel S, LaFranchi S, Bliziotes M. Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 1994, 79: 890-3.
14. Petersenn S, Heyens M, Lüdecke DK, Beil FU, Schulte HM. Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomas. Clin Endocrinol (Oxf) 2000, 52: 35-42.
15. Santarpia L, El-Naggar AK, Cote GJ, Myers JN, Sherman SI. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. J Clin Endocrinol Metab 2008, 93: 278-84.
16. Ballaré E, Mantovani S, Bassetti M, Lania A, Spada A. Immunodetection of G proteins in human pituitary adenomas: evidence for a low expression of proteins of the Gi subfamily. Eur J Endocrinol 1997, 137: 482-9.
17. Menzaghi C, Paroni G, De Bonis C, et al. The -318 C>G single-nucleotide polymorphism in GNAI2 gene promoter region impairs transcriptional activity through specific binding of SpI transcription factor and is associated with high blood pressure in Caucasians from Italy. J Am Soc Nephrol 2006, 17 (Suppl 2): S115-9.
18. Zhang X, Horwitz GA, Heaney AP, et al. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 1999, 84: 761-7.